Monoclonal Antibody Therapies at Bergen New Bridge

Monoclonal Antibody COVID-19 Treatment

We now offer a new monoclonal antibody COVID-19 treatment called Bebtelovimab. Monoclonal antibody treatment is a therapy for individuals who:

  • Have been near someone who is COVID positive (masked or unmasked) in the last 48 hours or who lives with someone who is COVID positive.
  • Are currently experiencing mild to moderate COVID-19 symptoms but are not hospitalized.
  • Are within ten days of the initial onset of symptoms.

This treatment involves a single infusion of antibodies from laboratory-made proteins mimicking the immune system’s ability to fight off viruses. Monoclonal antibody treatment is available to those who meet specific high-risk medical requirements.

Call our Central Scheduling team at 201.225.7130 to schedule a telehealth session to determine if the monoclonal antibody treatment will benefit you.

Long-Acting Monoclonal Antibodies Treatment

We now offer AstraZeneca’s Evusheld, a long-acting monoclonal antibodies treatment. Our care team will administer Evusheld in two separate shots in the same treatment session. We give this preventative therapy to patients who:

  • Have not been exposed to the SARS-CoV-2 (COVID-19) virus.
  • Are 12 years of age and older and weigh at least 40 kilograms [about 88 pounds].
  • Have moderate to severely compromised immune systems due to a medical condition or who are taking immunosuppressive medications or treatments that may inhibit developing an effective immune response using the approved COVID-19 vaccines, or
  • Have a history of severe adverse reactions to COVID-19 or components of the vaccines, so vaccination with an available COVID-19 vaccine is not recommended.

To receive long-acting monoclonal antibodies treatment requires a telehealth appointment to assess and schedule the therapy for qualifying patients. To schedule a telehealth assessment, call our Central Scheduling team at 201.225.7130.

We do not recommend Evusheld for pre-exposure prevention for individuals for whom standard COVID-19 immunization is safe and effective. 

Related Locations

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.